123 related articles for article (PubMed ID: 8792467)
1. Impact of the discovery of membrane inhibitors of complement.
Atkinson JP
Res Immunol; 1996 Feb; 147(2):95-100. PubMed ID: 8792467
[No Abstract] [Full Text] [Related]
2. Complement: the Iceman of immunology?
Würzner R
Immunopharmacology; 1997 Dec; 38(1-2):63-4. PubMed ID: 9476115
[TBL] [Abstract][Full Text] [Related]
3. Effect of transfectant molecules, MCP, DAF, and MCP/DAF hybrid on xenogeneic vascular endothelium.
Miyagawa S; Shirakura R; Izutani H; Matsumiya G; Nakata S; Matsuda H; Iwata K; Nagasawa S; Terado A; Matsumoto M
Transplant Proc; 1994 Jun; 26(3):1253-4. PubMed ID: 7518122
[No Abstract] [Full Text] [Related]
4. Altered expression of membrane inhibitors of complement in human gastric epithelium during Helicobacter-associated gastritis.
Sasaki M; Joh T; Tada T; Okada N; Yokoyama Y; Itoh M
Histopathology; 1998 Dec; 33(6):554-60. PubMed ID: 9870151
[TBL] [Abstract][Full Text] [Related]
5. Expression of decay-accelerating factor is reduced on hyperplastic synovial lining cells in rheumatoid synovitis.
Itoh J; Nose M; Fujita T; Kato M; Ohyama A; Kyogoku M
Clin Exp Immunol; 1991 Mar; 83(3):364-8. PubMed ID: 1706235
[TBL] [Abstract][Full Text] [Related]
6. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
[TBL] [Abstract][Full Text] [Related]
7. A novel chicken membrane-associated complement regulatory protein: molecular cloning and functional characterization.
Inoue N; Fukui A; Nomura M; Matsumoto M; Nishizawa Y; Toyoshima K; Seya T
J Immunol; 2001 Jan; 166(1):424-31. PubMed ID: 11123320
[TBL] [Abstract][Full Text] [Related]
8. Expression of complement regulatory factors using heterologous promoters in transgenic mice.
Kagan D; Platt J; Logan J; Byrne GW
Transplant Proc; 1994 Jun; 26(3):1242. PubMed ID: 7518118
[No Abstract] [Full Text] [Related]
9. Protection from complement-mediated cytolysis in cross-species hepatocytes transfected with complement regulatory factor (HRF20) using retroviral vector.
Hayashi S; Isobe K; Emi N; Kasai Y; Yokoyama I; Takagi H
Transplant Proc; 1994 Jun; 26(3):1252. PubMed ID: 7518121
[No Abstract] [Full Text] [Related]
10. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M
Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143
[No Abstract] [Full Text] [Related]
11. Ex vivo perfusion of mouse hearts expressing the human complement regulatory protein CD59.
Harland RC; Logan JS; Kooyman D; Byrne GW; Platt JL
Transplant Proc; 1994 Jun; 26(3):1245. PubMed ID: 7518120
[No Abstract] [Full Text] [Related]
12. Expression of human decay accelerating factor in transgenic pigs.
Cozzi E; Langford GA; Richards A; Elsome K; Lancaster R; Chen P; Yannoutsos N; White DJ
Transplant Proc; 1994 Jun; 26(3):1402-3. PubMed ID: 7518135
[No Abstract] [Full Text] [Related]
13. Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo model.
Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Melli C; Bruzzone P; Alfani D
Transplant Proc; 1996 Apr; 28(2):589. PubMed ID: 8623287
[No Abstract] [Full Text] [Related]
14. Protection of host from its own complement by membrane-bound complement inhibitors: C3 convertase inhibitors vs membrane attack complex inhibitors.
Kinoshita T
Res Immunol; 1996 Feb; 147(2):100-3. PubMed ID: 8792468
[No Abstract] [Full Text] [Related]
15. Mice transgenic for human CD46 and CD55 are protected from human complement attack.
Mulder LC; Mora M; Ciccopiedi E; Melli C; Nuti S; Marinucci G; Bruzzone P; Lazzeri M; Lorenzini R; Alfani D
Transplant Proc; 1995 Feb; 27(1):333-5. PubMed ID: 7533403
[No Abstract] [Full Text] [Related]
16. Production of pigs transgenic for human regulators of complement activation using YAC technology.
Langford GA; Cozzi E; Yannoutsos N; Lancaster R; Elsome K; Chen P; White DJ
Transplant Proc; 1996 Apr; 28(2):862-3. PubMed ID: 8623438
[No Abstract] [Full Text] [Related]
17. The change of membrane complement regulatory protein in chorion of early pregnancy.
Nishikori K; Noma J; Hirakawa S; Amano T; Kudo T
Clin Immunol Immunopathol; 1993 Nov; 69(2):167-74. PubMed ID: 7691457
[TBL] [Abstract][Full Text] [Related]
18. Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts.
Rosengard AM; Cary N; Horsley J; Belcher C; Langford G; Cozzi E; Wallwork J; White DJ
Transplant Proc; 1995 Feb; 27(1):326-7. PubMed ID: 7533400
[No Abstract] [Full Text] [Related]
19. Production of pigs transgenic for human regulators of complement activation.
Yannoutsos N; Langford GA; Cozzi E; Lancaster R; Elsome K; Chen P; White DJ
Transplant Proc; 1995 Feb; 27(1):324-5. PubMed ID: 7533399
[No Abstract] [Full Text] [Related]
20. Synthesis of aberrant decay-accelerating factor proteins by affected paroxysmal nocturnal hemoglobinuria leukocytes.
Carothers DJ; Hazra SV; Andreson SW; Medof ME
J Clin Invest; 1990 Jan; 85(1):47-54. PubMed ID: 1688570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
